Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome ; volume:21 ; number:1 ; day:30 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
BMC nephrology ; 21, Heft 1 (30.11.2020), 1-11, 12.2020
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-020-02153-5
- URN
-
urn:nbn:de:101:1-2021010907141768812121
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Basu, Biswanath
- Erdmann, Stella
- Sander, Anja
- Mahapatra, T. K. S.
- Schaefer, Franz
- SpringerLink (Online service)
Other Objects (12)
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
Rituximab for nephrotic syndrome in children
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
Rituximab for nephrotic syndrome in children
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
Rituximab for nephrotic syndrome in children
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report